Microvesicle Purification by Precipitation Without Integrity Loss

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for isolating microvesicles from biological fluids often damage their structural and functional integrity, leading to adverse reactions if used and are inefficient in providing sufficient quantities for diagnostic or therapeutic applications.

Innovation Solution

A method utilizing a precipitation agent to precipitate microvesicles from biological fluids by displacing water of solvation, followed by clarification, collection, and washing to maintain their integrity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If ultracentrifugation is used to isolate microvesicles, then microvesicles can be separated from biological fluids, but their structural and functional integrity is damaged

Engineering Contradiction:
Improvemicrovesicle isolation quantityVSAvoidmicrovesicle structural and functional integrity
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention changes the physical parameters of the isolation process by using precipitation agents (such as polyethylene glycol) to alter the solubility and phase state of microvesicles in the biological fluid, allowing them to precipitate out without the high-speed centrifugal forces that cause structural damage. This parameter change enables isolation while preserving integrity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the mechanical ultracentrifugation system with a chemical precipitation system. Instead of using mechanical centrifugal force to separate microvesicles, the method uses chemical agents to induce precipitation, thereby eliminating the mechanical stress that damages microvesicle structure and function.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Quantity of substance

If traditional isolation methods are used, then microvesicles can be obtained, but sufficient quantities for diagnostic or therapeutic applications are not provided

Engineering Contradiction:
Improvemicrovesicle quantityVSAvoidisolation efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

By adjusting parameters such as precipitation agent concentration, temperature, and pH, the invention optimizes the isolation process to maximize both the quantity of microvesicles obtained and the efficiency of the isolation procedure, providing sufficient quantities for diagnostic and therapeutic applications.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively isolates and purifies microvesicles without damage, enabling their use for therapeutic applications such as wound healing, tissue regeneration, and disease diagnosis, and enhances the preservation of their structural and functional integrity.

Implementation Method 1

A method utilizing a precipitation agent to precipitate microvesicles from biological fluids by displacing water of solvation

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS20260091064A1Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
Publication Date: 2026.04.02 UNIV OF MIAMI
  • US20260091064A1 patent drawing
  • US20260091064A1 patent drawing
  • US20260091064A1 patent drawing

AI summary

The present invention relates to the fields of medicine, cell biology, molecular biology and genetics. In particular, the present invention provides methods to isolate and purify microvesicles from cell culture supernatants and biological fluids. The present invention also provides pharmaceutical compositions of microvesicles to promote or enhance wound healing, stimulate tissue regeneration, remodel scarred tissue, modulate immune reactions, alter neoplastic cell growth and/or mobility, or alter normal cell growth and/or mobility. The present invention also provides compositions of microvesicles to be used as diagnostic reagents, and methods to prepare the compositions of microvesicles.